肾造口设备市场规模、份额和成长分析（按产品、最终用户和地区）- 产业预测 2025-2032

2023 年全球肾造口设备市场规模价值 13 亿美元，预计将从 2024 年的 14.1 亿美元成长到 2032 年的 27.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.6%。

肾造口设备市场正在经历显着增长，原因是以尿道结石，影响了全球12％的人口，并且预计肾癌病例数也会增加，到2023年美国预计将有81,800例新病例。肾臟疾病的激增推动了对肾造口设备的需求，尤其是对于因癌症而面临闭尿症的患者。另一个市场动态是微创手术（MIS）的趋势。这些技术比传统手术具有显着的优势，包括更短的恢復时间和降低併发症的风险。儘管成长前景良好，但替代治疗方案和相关风险等挑战可能会阻碍市场扩张，在製定策略时需要仔细考虑这些因素。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

肾造口设备市场规模（依产品及复合年增长率） (2025-2032)

• 市场概况
• 导管导引线
• 引流管
• 肾造口导管
• 鞘套扩张器
• 其他的

肾造口设备市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 急诊室
• 门诊手术中心（ASC）
• 其他的

肾造口设备市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Boston Scientific Corporation（United States）
• Teleflex Incorporated（United States）
• Becton, Dickinson and Company（United States）
• B. Braun SE（Germany）
• Cook Medical Incorporated（United States）
• Coloplast Group（Denmark）
• Olympus Corporation（Japan）
• Medtronic plc（Ireland）
• AngioDynamics Inc.（United States）
• Envaste Limited（United Kingdom）
• Medi-Globe GmbH（Germany）
• UROMED Kurt Drews KG（Germany）
• ROCAMED（France）
• Amecath（Egypt）
• SURGIMEDIK（India）
• Well Lead Medical Co., Ltd.（China）
• TROGE MEDICAL GmbH（Germany）
• Porges SA（France）
• Allium Medical Solutions Ltd.（Israel）

结论和建议

Global Nephrostomy Device Market size was valued at USD 1.3 billion in 2023 and is poised to grow from USD 1.41 billion in 2024 to USD 2.73 billion by 2032, growing at a CAGR of 8.6% during the forecast period (2025-2032).

The nephrostomy devices market is experiencing significant growth driven by the increasing prevalence of kidney disorders, notably urolithiasis affecting 12% of the global population, and the forecasted rise in kidney cancer cases, with an estimated 81,800 new instances in the U.S. for 2023. This surge in kidney disease incidences fuels demand for nephrostomy devices, especially for patients facing urinary blockages due to cancer. Additionally, the trend towards minimally invasive surgical procedures (MIS) is shaping market dynamics, as these techniques provide substantial benefits over traditional surgery, including shorter recovery times and lower risk of complications. Despite favorable growth prospects, challenges such as alternative treatment options and associated risks may impede market expansion, necessitating careful consideration of these factors in strategic planning.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nephrostomy Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nephrostomy Device Market Segmental Analysis

Global Nephrostomy Device Market is segmented by Product, End User and region. Based on Product, the market is segmented into Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators and Others. Based on End User, the market is segmented into Hospital, Emergency Clinics, Ambulatory Surgical Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nephrostomy Device Market

The global nephrostomy device market is significantly driven by ongoing technological advancements that enhance the performance and safety of these medical devices. Innovations such as superior catheter materials, state-of-the-art imaging techniques for precise placement, and advanced drainage systems have markedly improved the efficacy of nephrostomy procedures. As healthcare providers increasingly prioritize the adoption of cutting-edge, efficient devices to optimize patient outcomes, the demand for these innovative nephrostomy solutions continues to rise. This trend highlights the importance of technological evolution in propelling market growth and meeting the evolving needs of medical professionals and patients alike.

Restraints in the Global Nephrostomy Device Market

The global nephrostomy device market faces significant restraints primarily due to the high costs associated with these devices. The expense goes beyond the price of the nephrostomy devices themselves, as it also encompasses necessary consumables and accessories integral to the procedure. This financial burden can hinder the adoption of these devices in various healthcare environments and regions, particularly in facilities with constrained budgets. Additionally, patients experiencing financial difficulties may find it challenging to afford the treatment, further limiting market growth and accessibility. As a result, the high costs remain a crucial obstacle for widespread utilization of nephrostomy devices.

Market Trends of the Global Nephrostomy Device Market

The Global Nephrostomy Device market is experiencing a notable shift towards disposable nephrostomy devices, driven by their clear advantages over traditional reusable options. The increased emphasis on patient safety in healthcare settings has led to a rising adoption of these single-use devices, as they significantly reduce the risks associated with cross-contamination and infection transmission. Furthermore, the convenience and ease of use offered by disposable devices streamline clinical workflows, minimizing the complexities associated with reprocessing and sterilization. This trend indicates a market evolution, with healthcare facilities prioritizing safety and efficiency, thereby enhancing overall patient care and outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Nephrostomy Device Market Size by Product & CAGR (2025-2032)

• Market Overview
• Guidewires
• Drainage Tubes
• Nephrostomy Catheters
• Sheath Dilators
• Others

Global Nephrostomy Device Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital
• Emergency Clinics
• Ambulatory Surgical Centers (ASCs)
• Others

Global Nephrostomy Device Market Size & CAGR (2025-2032)

• North America (Product, End User)
  • US
  • Canada
• Europe (Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast Group (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Envaste Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medi-Globe GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UROMED Kurt Drews KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ROCAMED (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amecath (Egypt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SURGIMEDIK (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Well Lead Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TROGE MEDICAL GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Porges SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allium Medical Solutions Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations